Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Alimentary Pharmacology & Therapeutics|October 15, 2015
Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERDB Håkansson, M Montgomery, G B Cadiere, et al.Gut|October 1, 2008
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediatorsT Piche, G Barbara, P Aubert, et al.Alimentary Pharmacology & Therapeutics|July 12, 2008
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patientsE Coron, V Sebille, G Cadiot, et al.Alimentary Pharmacology & Therapeutics|July 7, 2015
Chemotherapy-driven dysbiosis in the intestinal microbiomeE Montassier, T Gastinne, P Vangay, et al.Clinics and Research in Hepatology and Gastroenterology|March 25, 2020
Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients' associationJ M Sabaté, P Ducrotté, T Piche, et al.Alimentary Pharmacology & Therapeutics|November 5, 2005
Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjectsF Zerbib, S Bruley des Varannes, S Roman, et al.Revue Des Maladies Respiratoires|April 20, 2023
[Guidelines for the management of chronic cough in adults]L Guilleminault, S Demoulin-Alexikova, L de Gabory, et al.Neurogastroenterology and Motility|October 14, 2017
Glioplasticity in irritable bowel syndromeN L Lilli, L Quénéhervé, S Haddara, et al.Alimentary Pharmacology & Therapeutics|February 7, 2017
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndromeC Cremon, V Stanghellini, M R Barbaro, et al.Gut|July 1, 1997
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxinC Cuillière, P Ducrotté, F Zerbib, et al.Pageof 9